Health
Pfizer vaccine may be less effective for obese people, study suggests – ConsumerAffairs
Obesity may weaken the efficacy of the Pfizer/BioNTech COVID-19 vaccine, new data suggests. A team of researchers in Rome found that obese people who h
Photo (c) Karl Tapales – Getty Images
Obesity may weaken the efficacy of the Pfizer/BioNTech COVID-19 vaccine, new data suggests.
A team of researchers in Rome found that obese people who had received two doses of the vaccine produced only about half the number of antibodies in response. The scientists defined obese as having a body mass index (BMI) over 30.
The study looked at the effect of the vaccine on 248 health care workers seven days after they had received their final dose. Among those…
-
Business18 hours agoWarning! These ASX 200 shares were just downgraded
-
Business11 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Business16 hours ago2 monthly payers you’ll want to own in 2025 and beyond
-
Noosa News7 hours agoTwo-time Archibald Prize-winning painter William Robinson has died, aged 89